Tag | Content |
---|
EnhancerAtlas ID | HS105-36210 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr17:78866670-78867500 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
FOSL1 | MA0477.1 | chr17:78866808-78866819 | GATGAGTCACC | - | 6.32 | FOSL2 | MA0478.1 | chr17:78866809-78866820 | ATGAGTCACCC | - | 6.14 | JUNB | MA0490.1 | chr17:78866809-78866820 | ATGAGTCACCC | - | 6.32 | JUND | MA0491.1 | chr17:78866808-78866819 | GATGAGTCACC | - | 6.62 |
|
| Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
SE_18550 | chr17:78861885-78868291 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19273 | chr17:78862224-78868150 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_61523 | chr17:78834447-78912815 | Toledo | SE_65227 | chr17:78864301-78867769 | NHEK |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH17I080889 | chr17 | 78862917 | 78867662 |
|
Enhancer Sequence | TAAGATCCTG GAAATCGGGT TATTGGATTG GGAGAGATTG GGGTTGTTTT TTCTGAAACA 60 CTGTATCTGA GTAAGCACCA CTCTGCCCCT GCCCCTTCGT CTAAGTGCGT GCCCTGAAGT 120 CCCATCTGCC AACATGGTGA TGAGTCACCC TTCCAGACGT GAGCATGGCA AGGAGGCGTA 180 GGCCAGCCCC CAGAATAGCC AGCGGGCCCG TTACCAATGC GGCAGGGAGC TCAAGCGCAG 240 CCGCAGTTGA GGCGGTGGCT CCTTGGAGGG CTGTGCCCTG CCCCCGTCTC CCAGTAACCT 300 GTGGTCTGCG GGTGGGGAGC TTGGCTCCCA GGGAGATCAG TGAGTGCCTG TGCCTGTGTG 360 TGCGCCGGGG CGTGTGTGCC AGGGTGTGTG CGCCAGGGTG CGTGTGTACC AGGGTGTGTG 420 TGCGCCGGGT GTGTGTGTGC GCCAGGTGTG TGCGCGCGCC AGGTGTGTGT GCGCCAGGGT 480 GTGTGTGTGC TGGGTGTGTG TGCACAAGGG TGTGTGCATG CCAGGGTGTG TGTGTGTGTG 540 TACAAGGGTG TGTGTGTGCC AGGGTGTGTG TACTGGGTGT GTATACGCGC CAGGTTGTGT 600 CTGTACGCGC CAGGGTGTGT GCGCCAGGGT GTGTGTGTAT GAGGGTGTGT GTATGTCGGG 660 TGTGTGTACA TGCCAGGGTG TGTGCGCACC AGGGTGTGTG TGTACCAGGG TGTGTTTGTG 720 CCTGGGTGTG CTGAGCTTTA TTTAGAAGAA AATATGTATC TCAGTCATGC CATTAACTGT 780 AAGACCAAAA GGAGGGTCCC GGGAGCACCC CACTGACCCC GTTGCGTCTC 830
|